Maynard Um
-
-
-
-
-
-
-
Incyte gets positive CHMP opinion for anal cancer drug Zynyz
-
-
-
-
-
-
-
INCYTE wins European approval for Minjuvi cancer treatment
-
-
-
-
-
-
-
FDA grants breakthrough therapy designation to INCA033989 for blood cancer
-
-
-
-
-
-
-
Incyte (INCY) PT Raised to $109 at BofA Securities
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Perform Rating on Incyte (INCY)
-
-
-
-
-
-
-
Incyte (INCY) Misses Q2 EPS by 140c
-
-
-
-
-
-
-
Incyte (INCY) Appoints Bill Meury as Next CEO
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

